⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20295697 | 1.00 | — | — | |
| SCHEMBL20295933 | 1.00 | — | — | |
| SCHEMBL1864577 | 0.92 | — | — | |
| SCHEMBL1868510 | 0.92 | — | — | |
| SCHEMBL1864575 | 0.92 | — | — | |
| SCHEMBL5966226 | 0.90 | POLB (0.36) | — | |
| SCHEMBL5966260 | 0.86 | — | — | |
| SCHEMBL242415 | 0.80 | — | — | |
| SCHEMBL14398568 | 0.80 | — | — | |
| SCHEMBL28000893 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 844 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220194931-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | INCYTE CORPORATION | 2022-06-23 | — | — | US | claimed |
| CN-110582493-A | Benzoxazole derivatives as immunomodulators | 因赛特公司 | 2019-12-17 | — | — | CN | claimed |
| EP-3558985-A1 | BENZOOXAZOLE DERIVATIVES AS IMMUNOMODULATORS | Incyte Corporation (US) | 2019-10-30 | — | — | EP | claimed |
| US-20180179197-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | INCYTE CORPORATION | 2018-06-28 | — | — | US | claimed |
| WO-2018119266-A1 | BENZOOXAZOLE DERIVATIVES AS IMMUNOMODULATORS | INCYTE CORPORATION (US) | 2018-06-28 | — | — | WO | claimed |
| CN-101410414-A | Synergistic compositions for treating HIV-1 | ROCHE PALO ALTO LLC (CH) | 2009-04-15 | — | — | CN | claimed |
| US-20080299132-A1 | Synergistic compositions for treating HIV-1 | ROCHE PALO ALTO LLC | 2008-12-04 | — | — | US | claimed |
| EP-1981911-A2 | SYNERGISTIC COMPOSITIONS FOR TREATING HIV | F.HOFFMANN-LA ROCHE AG (CH) | 2008-10-22 | — | — | EP | claimed |
| WO-2007085567-A2 | SYNERGISTIC COMPOSITIONS FOR TREATING HIV | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-02 | — | — | WO | claimed |
| US-20060025345-A1 | Substituted ethane-1,2-diamines for the treatment of Alzheimer's disease | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-02-02 | — | — | US | claimed |
| WO-2005113582-A1 | SUBSTITUTED ETHANE-1,2-DIAMINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-12-01 | — | — | WO | claimed |
| US-20020037872-A1 | N6 heterocyclic 5' modified adenosine derivatives | CV THERAPEUTICS, INC. | 2002-03-28 | — | — | US | claimed |
| US-6258793-B1 | MODIFYING CARDIAC ACTIVITY, MODIFYING ADIPOCYTE FUNCTION, TREATING CENTRAL NERVOUS SYSTEM DISORDERS, AND TREATING DIABETIC DISORDERS AND OBESITY IN MAMMALS | CV THERAPEUTICS, INC. | 2001-07-10 | — | — | US | claimed |
| WO-2001040245-A1 | N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES | CV THERAPEUTICS, INC. (US) | 2001-06-07 | — | — | WO | claimed |
| WO-2001040244-A1 | N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES | CV THERAPEUTICS, INC. (US) | 2001-06-07 | — | — | WO | claimed |
| US-12043601-B2 | N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2024-07-23 | — | — | US | disclosed |
| WO-2024151969-A1 | POTASSIUM CHANNEL BLOCKERS OR DERIVATIVES THEREOF FOR PREVENTING, ALLEVIATING, AND/OR TREATING MORBIDITY AND MORTALITY INDUCED BY PATHOGENS OR OTHER INDUCERS OF IMMUNE EXHAUSTION AND/OR EXCESS IMMUNE ACTIVATION | UNIVERSITY OF ROCHESTER (US) | 2024-07-18 | — | — | WO | disclosed |
| EP-0313081-A2 | 2-Oxa-isocephem compounds, compositions containing the same and processes for preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-04-26 | — | — | EP | disclosed |
| US-4151268-A | ASSAYING FOR 5-SUBSTITUTED-1,3-UNSUBSTITUTED BARBITURIC ACIDS BY COMPLEXING WITH GAMMA GLOBULIN FRACTION PROTEINS | HOFFMANN-LA ROCHE INC. (US) | 1979-04-24 | — | — | US | disclosed |
| US-4107157-A | Barbituric acid antigens and antibodies specific therefor | HOFFMANN-LA ROCHE INC. (US) | 1978-08-15 | — | — | US | disclosed |